Skip to main content

Main menu

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Subscribers
    • Advertisers
    • Editorial Board
    • Special Issues 2025
  • Journal Metrics
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics

User menu

  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Anticancer Research
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics
  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Anticancer Research

Advanced Search

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Subscribers
    • Advertisers
    • Editorial Board
    • Special Issues 2025
  • Journal Metrics
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Visit us on Facebook
  • Follow us on Linkedin

risk factor

  • You have access
    Loss of Skeletal Muscle Mass During Neoadjuvant Chemotherapy for Pancreatic Cancer Is Related to the Continuation of S-1 Adjuvant Chemotherapy After Pancreatectomy
    SHINNOSUKE KAWAHARA, TORU AOYAMA, ITARU HASHIMOTO, REI KANEMOTO, NAOHIKO MATSUSHITA, MARIKO KAMIYA, YOSUKE ATSUMI, YUKIO MAEZAWA, KEISUKE KAZAMA, MASAAKI MURAKAWA, SATOSHI KOBAYASHI, MAKOTO UENO, NAOTO YAMAMOTO, TAKASHI OSHIMA, NORIO YUKAWA, AYA SAITO and SOICHIRO MORINAGA
    Anticancer Research October 2024, 44 (10) 4569-4577; DOI: https://doi.org/10.21873/anticanres.17286
  • You have access
    Risk Factors for Non-sentinel Lymph Node Metastasis in HR+/HER2− Breast Cancer With cN0
    YONG MIN NA, SANG CHUN PARK, YOUNG JAE RYU, JIN SEONG CHO and MIN HO PARK
    Anticancer Research August 2024, 44 (8) 3493-3500; DOI: https://doi.org/10.21873/anticanres.17169
  • Open Access
    Serum Creatinine Elevation as a Risk Factor for Niraparib-induced Hematologic Toxicity
    KOKI HASHIMOTO, KAZUYOSHI KAWAKAMI, TAKASHI YOKOKAWA, NAOKI SHIBATA, AZUSA SOEJIMA, TAKAHITO SUGISAKI, YUKA MORI, HISANORI SHIMIZU, MAYU YUNOKAWA, HIROYUKI KANAO and MASAKAZU YAMAGUCHI
    Anticancer Research October 2023, 43 (10) 4533-4541; DOI: https://doi.org/10.21873/anticanres.16647
  • You have access
    Incidence and Risk of Venous Thromboembolism in Patients With Resectable Pancreatic Cancer Receiving Neoadjuvant Chemotherapy
    MARIKO KAMIYA, SHINNOSUKE KAWAHARA, YUTO KAMIOKA, MASAAKI MURAKAWA, TORU AOYAMA, SATOSHI KOBAYASHI, MAKOTO UENO, NAOTO YAMAMOTO, TAKASHI OSHIMA, NORIO YUKAWA, YASUSHI RINO, MUNETAKA MASUDA and SOICHIRO MORINAGA
    Anticancer Research April 2023, 43 (4) 1741-1747; DOI: https://doi.org/10.21873/anticanres.16327
  • You have access
    Risk of Abemaciclib-induced Liver Injury in Hormone Receptor-positive, HER2-negative Metastatic Breast Cancer: A Retrospective Analysis
    AZUSA TANIGUCHI, NOBUYOSHI KITTAKA, HARUKA KANAOKA, SATOMI NAKAJIMA, YURI OYAMA, YUKIKO SETO, AI SOMA, HIROKI KUSAMA, NORIYUKI WATANABE, SAKI MATSUI, MINAKO NISHIO, FUMIE FUJISAWA and TAKAHIRO NAKAYAMA
    Anticancer Research December 2022, 42 (12) 6027-6035; DOI: https://doi.org/10.21873/anticanres.16114
  • You have access
    Risk Factor Analysis for the Occurrence of Severe Adverse Effects in Eribulin Treatment
    YOSHITAKA SAITO, YOH TAKEKUMA, TAKASHI TAKESHITA, TAKURO NOGUCHI, SATOSHI TAKEUCHI, YASUSHI SHIMIZU, ICHIRO KINOSHITA, HIROTOSHI DOSAKA-AKITA and MITSURU SUGAWARA
    Anticancer Research July 2022, 42 (7) 3693-3700; DOI: https://doi.org/10.21873/anticanres.15858
  • You have access
    Suitability of Oral Rehydration Solution (ORS) for Use in the Cisplatin Short Hydration Method
    YOSHITAKA SAITO, YOH TAKEKUMA, MASAKI KOBAYASHI, NAOFUMI SHINAGAWA, TAKURO NOGUCHI, SATOSHI TAKEUCHI, YASUSHI SHIMIZU, ICHIRO KINOSHITA, HIROTOSHI DOSAKA-AKITA and MITSURU SUGAWARA
    Anticancer Research June 2022, 42 (6) 3185-3193; DOI: https://doi.org/10.21873/anticanres.15808
  • You have access
    Risk Factors and Overcoming Strategies of Surgical Site Infection After Hepatectomy for Colorectal Liver Metastases
    KENEI FURUKAWA, SHINJI ONDA, TOMOHIKO TANIAI, RYOGA HAMURA, MITSURU YANAGAKI, MASASHI TSUNEMATSU, KOICHIRO HARUKI, JUNGO YASUDA, TARO SAKAMOTO, TAKESHI GOCHO and TORU IKEGAMI
    Anticancer Research November 2021, 41 (11) 5651-5656; DOI: https://doi.org/10.21873/anticanres.15381
  • You have access
    Pretreatment Platelet Count and Neutrophil/Lymphocyte Ratio Are Predictive Markers for Carboplatin Plus Pemetrexed Therapy-induced Thrombocytopenia
    MASAYA TAKAHASHI, KATSUYUKI TAKAHASHI, HIROYASU KANEDA, TOMOYA KAWAGUCHI and KATSUYA NAGAYAMA
    Anticancer Research November 2021, 41 (11) 5729-5737; DOI: https://doi.org/10.21873/anticanres.15389
  • You have access
    Risk Factors for Postoperative Deep Infection After Malignant Bone Tumor Surgery of the Extremities
    MICKHAEL BANG LANGIT, SHINJI MIWA, NORIO YAMAMOTO, KATSUHIRO HAYASHI, AKIHIKO TAKEUCHI, KENTARO IGARASHI, KAORU TADA, TAKASHI HIGUCHI, HIROTAKA YONEZAWA, SEI MORINAGA, YOSHIHIRO ARAKI, YOHEI ASANO and HIROYUKI TSUCHIYA
    Anticancer Research June 2020, 40 (6) 3551-3557; DOI: https://doi.org/10.21873/anticanres.14344

Pages

  • Next
  • 1
  • 2
Anticancer Research

© 2025 Anticancer Research

Powered by HighWire